- Home
- PB vs BIO Comparison
PB vs BIO Comparison
Compare PB & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PB
- BIO
- Stock Information
- Founded
- PB 1983
- BIO 1952
- Country
- PB United States
- BIO United States
- Employees
- PB N/A
- BIO N/A
- Industry
- PB Major Banks
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- PB Finance
- BIO Industrials
- Exchange
- PB Nasdaq
- BIO Nasdaq
- Market Cap
- PB 7.0B
- BIO 6.0B
- IPO Year
- PB 1998
- BIO N/A
- Fundamental
- Price
- PB $73.18
- BIO $245.57
- Analyst Decision
- PB Buy
- BIO Strong Buy
- Analyst Count
- PB 15
- BIO 4
- Target Price
- PB $83.64
- BIO $324.25
- AVG Volume (30 Days)
- PB 705.4K
- BIO 251.2K
- Earning Date
- PB 07-23-2025
- BIO 07-31-2025
- Dividend Yield
- PB 3.20%
- BIO N/A
- EPS Growth
- PB 20.96
- BIO N/A
- EPS
- PB 5.23
- BIO N/A
- Revenue
- PB $1,212,807,000.00
- BIO $2,541,100,000.00
- Revenue This Year
- PB $11.47
- BIO N/A
- Revenue Next Year
- PB $7.66
- BIO $3.42
- P/E Ratio
- PB $13.85
- BIO N/A
- Revenue Growth
- PB 11.62
- BIO N/A
- 52 Week Low
- PB $61.57
- BIO $211.43
- 52 Week High
- PB $86.76
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- PB 52.62
- BIO 51.18
- Support Level
- PB $72.32
- BIO $244.45
- Resistance Level
- PB $74.40
- BIO $252.49
- Average True Range (ATR)
- PB 1.33
- BIO 6.36
- MACD
- PB -0.15
- BIO -1.13
- Stochastic Oscillator
- PB 35.21
- BIO 21.81
About PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.